Inlyta 5mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Axitinib (5mg)
Overview Inlyta 5mg Tablet
Axitinib 5mg tablets are prescribed for kidney cancer treatment. This anti-cancer medication can be administered with or without food; however, consistent daily timing maximizes effectiveness. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may not be evident immediately; continued use is crucial unless otherwise directed by your doctor. Common side effects include hypertension, arthralgia, and anorexia. While diarrhea and dyspnea may sometimes become serious, address these with prescribed medication or adequate hydration. Regular blood pressure monitoring is often recommended during treatment. Report severe headaches, disorientation, visual disturbances, nausea, or vomiting to your physician. Prior to commencing treatment, disclose any thyroid conditions, hepatic dysfunction, bleeding disorders, or use of antimicrobial agents. Inform your healthcare provider of all medications being taken, as interactions are possible. This medication is contraindicated during pregnancy and lactation; women of childbearing age should use reliable contraception during treatment.
Uses of Inlyta 5mg Tablet
Renal cell carcinoma
Major Benefits of Inlyta 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Inlyta 5mg Tablet whole; do not break, crush, or chew it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Inlyta 5mg Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Inlyta 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 5mg Inlyta tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Inlyta 5mg Tablet works:
Sutent 5mg tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a faulty protein responsible for stimulating cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Inlyta 5mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Inlyta 5mg tablets is contraindicated during pregnancy due to confirmed risks to fetal development. In exceptional life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Inlyta 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Suvorexant 5mg tablets can reduce alertness, impair vision, and cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Axitinib 5mg tablets are safely administered to individuals with renal impairment. No alteration of the Axitinib 5mg tablet dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should use Inlyta 5mg tablets cautiously; dose modification may be necessary. Physician consultation is advised. Data regarding Inlyta 5mg tablet use in patients exhibiting severe liver dysfunction is limited.
What if you forget to take Inlyta 5mg Tablet :
NA
Facts to Know About Inlyta 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Indazole and Enzamide Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | TKIs (Tyrosine Kinase Inhibitors) |
3,018 People bought this recently